39 articles for BL Harrison
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Novel triazines as potent and selective phosphodiesterase 10A inhibitors.

Pfizer
Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2.

Wyeth Research
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1' substrate binding pocket.

Wyeth Research
Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity.

Wyeth Research
Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan.

Wyeth Research
Highly potent, selective, and orally active phosphodiesterase 10A inhibitors.

Pfizer
Discovery of imidazo[1,5-a]pyrido[3,2-e]pyrazines as a new class of phosphodiesterase 10A inhibitiors.

Biotie Therapies
The synthesis and biological evaluation of quinolyl-piperazinyl piperidines as potent serotonin 5-HT1A antagonists.

Pfizer
3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT(6) receptor modulators.

Wyeth Pharmaceuticals
Novel benzofuran derivatives with dual 5-HT1A receptor and serotonin transporter affinity.

Wyeth Research
Synthesis and structure-activity relationship of novel lactam-fused chroman derivatives having dual affinity at the 5-HT(1A) receptor and the serotonin transporter.

Wyeth Research
1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-pyrrolopyridines are 5-HT(6) receptor ligands.

Wyeth Research
Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonists.

Wyeth Research
Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonists.

Wyeth Research
Studies toward the discovery of the next generation of antidepressants. Part 6: Dual 5-HT1A receptor and serotonin transporter affinity within a class of arylpiperazinyl-cyclohexyl indole derivatives.

Wyeth Research
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pockets.

Wyeth Research
Novel pyridyl-fused 3-amino chroman derivatives with dual action at serotonin transporter and 5-HT1A receptor.

Wyeth Research
Breakthroughs in neuroactive steroid drug discovery.

Sage Therapeutics
Studies toward the discovery of the next generation of antidepressants. Part 5: 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives with dual 5-HT1A receptor and serotonin transporter affinity.

Wyeth Research
SAGE-718: A First-in-Class

Sage Therapeutics
Novel human metabolites of the angiotensin-II antagonist tasosartan and their pharmacological effects.

Wyeth Research
Neuroactive Steroid

Sage Therapeutics
Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.

Wyeth Research
Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)

Sage Therapeutics
3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site.

Marion Merrell Dow Research Institute
METHODS FOR TREATMENT OF CANCER

Frontier Medicines
PRMT5 INHIBITORS AND METHODS OF TREATMENT

Hangzhou Unogen Biotech
THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS

Terns Pharmaceuticals
Bicyclic amide compounds and methods of use thereof

Genentech
Tetrahydroisoquinoline derivatives, preparation process and use thereof

Sichuan Kelun-Biotech Biopharmaceutical
Use of aminomethylenecyclohexane-1,3-dione compound

Wigen Biomedicine Technology (Shanghai)
N2,N4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer

Korea Research Institute of Chemical Technology
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

Ideaya Bioscience
Substituted benzamides as RIPK2 inhibitors

Boehringer Ingelheim International
Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics

Stingray Therapeutics
Amino pyrimidine compound for inhibiting protein tyrosine kinase activity

Shenzhen Targetrx
Pyrimidine FGFR4 inhibitors

Eisai R&D Management
Inhibitors of lysine specific demethylase-1

Celgene Quanticel Research
Incontinence treatment methods

Ixaltis